Stéphane Richard

Title: Stéphane Richard: Innovator in Molecular Biology

Introduction

Stéphane Richard is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of molecular biology, particularly in the study of mammalian proteins. His work has implications for cancer research and therapeutic development.

Latest Patents

Stéphane Richard holds a patent for SLM-1, a novel Sam68-like mammalian protein. The patent describes two Sam68-like mammalian proteins, SLM-1 and SLM-2, along with nucleic acid molecules encoding them. The invention also includes expression vectors and cells capable of expressing these proteins, as well as antibodies that can specifically bind to them. Additionally, the patent discusses kits for the assay of tyrosine kinase activity, which may be utilized to determine whether a cell is cancerous. Furthermore, the invention relates to transgenic animals, such as knockout mice, which can be used to study the effects of test compounds on SLM-1 or SLM-2 deficiency.

Career Highlights

Stéphane Richard is affiliated with the Sir Mortimer B. Davis Jewish General Hospital, where he conducts his research. His work at this institution has allowed him to explore innovative approaches to understanding protein functions and their roles in disease.

Collaborations

Due to space constraints, the collaborations section has been omitted.

Conclusion

Stéphane Richard's contributions to molecular biology, particularly through his patent on SLM-1, highlight his role as an innovator in the field. His research has the potential to advance our understanding of cancer and improve therapeutic strategies.